T1	Disorder 0 18	Serotonin syndrome
N1 	Reference T1 UMLS:C0024586	Serotonin syndrome
N2 	Reference T1 UMLS:C0699828	Serotonin syndrome
T2	Pharmacological_substance 29 39	metaxalone
N1000 	Reference T2 MeSH:C011301	metaxalone
T4	Pharmacological_substance 114 124	Metaxalone
N1001 	Reference T4 MeSH:C011301	Metaxalone
T5	Disorder 164 182	serotonin syndrome
N3 	Reference T5 UMLS:C0024586	serotonin syndrome
N4 	Reference T5 UMLS:C0699828	serotonin syndrome
T6	Pharmacological_substance 216 248	centrally acting muscle relaxant
N1002 	Reference T6 MeSH:D009125	centrally acting muscle relaxant
T7	Disorder 289 307	serotonin syndrome
N5 	Reference T7 UMLS:C0024586	serotonin syndrome
N6 	Reference T7 UMLS:C0699828	serotonin syndrome
T8	Pharmacological_substance 325 335	metaxalone
N1003 	Reference T8 MeSH:C011301	metaxalone
T11	Pharmacological_substance 436 446	metaxalone
N1004 	Reference T11 MeSH:C011301	metaxalone
T12	Disorder 513 534	seizure-like activity
T13	Disorder 536 548	hyperthermia
N7 	Reference T13 UMLS:C0015967	hyperthermia
T14	Disorder 550 584	rigidity in the lower extremities,
T15	Disorder 585 594	myoclonus
N8 	Reference T15 UMLS:C0027066	myoclonus
T16	Disorder 600 613	hyperreflexia
N9 	Reference T16 UMLS:C0151889	hyperreflexia
T19	Pharmacological_substance 852 867	benzodiazepines
N1005 	Reference T19 MeSH:D001569	benzodiazepines
T20	Pharmacological_substance 896 906	paroxetine
N1006 	Reference T20 MeSH:D017374	paroxetine
T22	Pharmacological_substance 973 983	metaxalone
N1007 	Reference T22 MeSH:C011301	metaxalone
T27	Disorder 1202 1235	rigidity in his lower extremities
T28	Disorder 1237 1246	myoclonus
N10 	Reference T28 UMLS:C0027066	myoclonus
T29	Disorder 1252 1265	hyperreflexia
N11 	Reference T29 UMLS:C0151889	hyperreflexia
T32	Pharmacological_substance 1495 1505	metaxalone
N1008 	Reference T32 MeSH:C011301	metaxalone
T33	Pharmacological_substance 1510 1522	escitalopram
N1009 	Reference T33 MeSH:D015283	escitalopram
T34	Pharmacological_substance 1571 1579	diazepam
N1010 	Reference T34 MeSH:D003975	diazepam
T36	Pharmacological_substance 1632 1644	escitalopram
N1011 	Reference T36 MeSH:D015283	escitalopram
T39	Pharmacological_substance 1723 1733	metaxalone
N1012 	Reference T39 MeSH:C011301	metaxalone
T41	Pharmacological_substance 1827 1837	metaxalone
N1013 	Reference T41 MeSH:C011301	metaxalone
T42	Disorder 1871 1889	serotonin toxicity
T43	Pharmacological_substance 1906 1916	metaxalone
N1014 	Reference T43 MeSH:C011301	metaxalone
T44	Pharmacological_substance 1946 1984	selective serotonin reuptake inhibitor
N1015 	Reference T44 MeSH:D017367	selective serotonin reuptake inhibitor
T45	Pharmacological_substance 74 112	selective serotonin reuptake inhibitor
N1016 	Reference T45 MeSH:D017367	selective serotonin reuptake inhibitor
T17	Subject 1118 1135	A 27-year-old man
T23	Subject 399 418	A 29-year-old woman
T3	Combination 49 52	and
T25	Disorder 490 511	altered mental status
N12 	Reference T25 UMLS:C0278061	altered mental status
T30	Disorder 1179 1200	altered mental status
N13 	Reference T30 UMLS:C0278061	altered mental status
T35	Speculation_cue 1890 1893	may
